Ligand validation:1YE6

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1YE6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1YE6_NAD_D_1003	79%	14%	0.121	0.968	2.23	1.61	10	10	2	0	100%	1
1YE6_NAD_B_1001	70%	15%	0.142	0.96	2.2	1.59	13	11	1	0	100%	1
1MI3_NAD_D_4350	96%	14%	0.071	0.981	2.19	1.68	13	10	2	0	100%	1
1Z9A_NAD_D_4350	91%	15%	0.098	0.985	2.2	1.61	11	12	2	0	100%	1
1YE4_NAD_D_803	86%	15%	0.112	0.981	2.24	1.56	11	10	1	0	100%	1
1SM9_NAD_A_1350	80%	10%	0.111	0.96	2.17	2.21	12	13	3	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.